Systemic immune-inflammation index and ultrasonographic classification of breast imaging-reporting and data system predict outcomes of triple-negative breast cancer

References

• ChenWZhengRBaadePDCancer statistics in China, 2015CA Cancer J Clin201666211513226808342
   PubMed Web of Science ®Google Scholar
• SiegelRLMillerKDJemalACancer statistics, 2018CA Cancer J Clin201868173029313949
   PubMed Web of Science ®Google Scholar
• BianchiniGBalkoJMMayerIASandersMEGianniLTriple-negative breast cancer: challenges and opportunities of a heterogeneous diseaseNat Rev Clin Oncol2016131167469027184417
   PubMed Web of Science ®Google Scholar
• BrewsterAMChavez-MacgregorMBrownPEpidemiology, biology, and treatment of triple-negative breast cancer in women of African ancestryLancet Oncol20141513e625e63425456381
   PubMed Web of Science ®Google Scholar
• van RoozendaalLMSmitLHMDuijsensGRisk of regional recurrence in triple-negative breast cancer patients: a Dutch cohort studyBreast Cancer Res Treat2016156346547227013474
   PubMed Web of Science ®Google Scholar
• FoulkesWDSmithIEReis-FilhoJSTriple-negative breast cancerN Engl J Med2010363201938194821067385
   PubMed Web of Science ®Google Scholar
• YangJPengLSahinAABiology and management of patients with triple-negative breast cancerBreast Cancer Res Treat201621910501062
   Google Scholar
• CriscitielloCAzimHASchoutenPCLinnSCSotiriouCUnderstanding the biology of triple-negative breast cancerAnn Oncol2012236vi13vi1823012296
   PubMedGoogle Scholar
• BoschAErolesPZaragozaRViñaJRLluchATriple-negative breast cancer: molecular features, pathogenesis, treatment and current lines of researchCancer Treat Rev201036320621520060649
   PubMed Web of Science ®Google Scholar
• HanahanDWeinbergRAHallmarks of cancer: the next generationCell2011144564667421376230
   PubMed Web of Science ®Google Scholar
• MantovaniAAllavenaPSicaABalkwillFCancer-related inflammationNature2008454720343644418650914
   PubMed Web of Science ®Google Scholar
• WangKShenTSiegalGPWeiSThe CD4/CD8 ratio of tumor-infiltrating lymphocytes at the tumor–host interface has prognostic value in triple-negative breast cancerHum Pathol20176911011728993275
   PubMed Web of Science ®Google Scholar
• LiuCSunBXuBA panel containing PD-1, IL-2Rα, IL-10, and CA15-3 as a biomarker to discriminate breast cancer from benign breast diseaseCancer Manag Res2018101749176129983594
   PubMed Web of Science ®Google Scholar
• HuBYangXRXuYSystemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinomaClin Cancer Res201420236212622225271081
   PubMed Web of Science ®Google Scholar
• YangJGuoXWangMMaXYeXLinPPre-treatment inflammatory indexes as predictors of survival and cetuximab efficacy in metastatic colorectal cancer patients with wild-type RASSci Rep2017711716629215037
   PubMedGoogle Scholar
• AzizMHSiderasKAzizNAThe systemic-immune-inflammation index independently predicts survival and recurrence in resectable pancreatic cancer and its prognostic value depends on bilirubin levels: a retrospective multicenter cohort studyAnn Surg201811
   Google Scholar
• ChenLYanYZhuLSystemic immune-inflammation index as a useful prognostic indicator predicts survival in patients with advanced gastric cancer treated with neoadjuvant chemotherapyCancer Manag Res2017984986729276407
   PubMed Web of Science ®Google Scholar
• LolliCBassoUDerosaLSystemic immune-inflammation index predicts the clinical outcome in patients with metastatic renal cell cancer treated with sunitinibOncotarget2016734545645457127409344
   PubMedGoogle Scholar
• FanLWangRChiCSystemic immune-inflammation index predicts the combined clinical outcome after sequential therapy with abiraterone and docetaxel for metastatic castration-resistant prostate cancer patientsProstate201878425025629285775
   PubMed Web of Science ®Google Scholar
• TongYSTanJZhouXLSongYQSongYJSystemic immune-inflammation index predicting chemoradiation resistance and poor outcome in patients with stage III non-small cell lung cancerJ Transl Med201715122129089030
   PubMedGoogle Scholar
• JiangWChenYHuangJSystemic immune-inflammation index predicts the clinical outcome in patients with nasopharyngeal carcinoma: a propensity score-matched analysisOncotarget2017839660756608629029493
   PubMedGoogle Scholar
• ChenYChenKXiaoXPretreatment neutrophil-to-lymphocyte ratio is correlated with response to neoadjuvant chemotherapy as an independent prognostic indicator in breast cancer patients: a retrospective studyBMC Cancer20161632027198767
   PubMed Web of Science ®Google Scholar
• YaoMLiuYJinHPrognostic value of preoperative inflammatory markers in Chinese patients with breast cancerOnco Targets Ther201471743175225328407
   PubMed Web of Science ®Google Scholar
• PistelliMde LisaMBallatoreZPre-treatment neutrophil to lymphocyte ratio may be a useful tool in predicting survival in early triple negative breast cancer patientsBMC Cancer20151519525884918
   PubMed Web of Science ®Google Scholar
• LiuCHuangZWangQUsefulness of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in hormone-receptor-negative breast cancerOnco Targets Ther201694653466027536129
   PubMed Web of Science ®Google Scholar
• YamagishiTFujimotoNNishiHPrognostic significance of the lymphocyte-to-monocyte ratio in patients with malignant pleural mesotheliomaLung Cancer201590111111726259877
   PubMed Web of Science ®Google Scholar
• TempletonAJMcnamaraMGŠerugaBPrognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysisJ Natl Cancer Inst20141066dju12424875653
   PubMedGoogle Scholar
• KaoSCPavlakisNHarvieRHigh blood neutrophil-to-lymphocyte ratio is an indicator of poor prognosis in malignant mesothelioma patients undergoing systemic therapyClin Cancer Res201016235805581320956618
   PubMed Web of Science ®Google Scholar
• CannonNAMeyerJIyengarPNeutrophil-lymphocyte and platelet-lymphocyte ratios as prognostic factors after stereotactic radiation therapy for early-stage non-small-cell lung cancerJ Thorac Oncol201510228028525299234
   PubMed Web of Science ®Google Scholar
• SongSLiCLiSGaoHLanXXueYDerived neutrophil to lymphocyte ratio and monocyte to lymphocyte ratio may be better biomarkers for predicting overall survival of patients with advanced gastric cancerOnco Targets Ther2017103145315428706446
   PubMed Web of Science ®Google Scholar
• GrenaderTNashSPlotkinYDerived neutrophil lymphocyte ratio may predict benefit from cisplatin in the advanced biliary cancer: the ABC-02 and BT-22 studiesAnn Oncol20152691910191626037798
   PubMed Web of Science ®Google Scholar
• LiuCWuSMengXPredictive value of peripheral regulatory T cells in non-small cell lung cancer patients undergoing radiotherapyOncotarget2017826434274343828624781
   PubMedGoogle Scholar
• HoughtonAMRzymkiewiczDMJiHNeutrophil elastase-mediated degradation of IRS-1 accelerates lung tumor growthNat Med201016221922320081861
   PubMed Web of Science ®Google Scholar
• FrancoATCorkenAWareJPlatelets at the interface of thrombosis, inflammation, and cancerBlood2015126558258826109205
   PubMed Web of Science ®Google Scholar
• AliHRProvenzanoEDawsonSJAssociation between CD8+ T-cell infiltration and breast cancer survival in 12,439 patientsAnn Oncol20142581536154324915873
   PubMed Web of Science ®Google Scholar
• MohammedZMGoingJJEdwardsJMcMillanDCThe role of the tumour inflammatory cell infiltrate in predicting recurrence and survival in patients with primary operable breast cancerCancer Treat Rev201238894395522651904
   PubMed Web of Science ®Google Scholar
• GengYShaoYZhuDSystemic immune-inflammation index predicts prognosis of patients with esophageal squamous cell carcinoma: a propensity score-matched analysisSci Rep201663948228000729
   PubMed Web of Science ®Google Scholar
• FukudaHTakagiTKondoTShimizuSTanabeKPredictive value of inflammation-based prognostic scores in patients with metastatic renal cell carcinoma treated with cytoreductive nephrectomyOncotarget2018918142961430529581844
   PubMedGoogle Scholar
• HuangLLiuSLeiYSystemic immune-inflammation index, thymidine phosphorylase and survival of localized gastric cancer patients after curative resectionOncotarget2016728441854419327283904
   PubMedGoogle Scholar